Apolipoprotein E (APOE) polymorphisms and susceptibility to breast cancer: a meta-analysis

Cancer Research and Treatment

Volumn 44, Issue 2, 2012, Pages 121-126

  Saadat, Mostafa ^a  

^a SHIRAZ UNIVERSITY   (Iran)

Author keywords

Apolipoproteins E; Breast neoplasms; Disease susceptibility; Meta analysis

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; RISK;

EID: 84866948234     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2012.44.2.121     Document Type: Article

References (25)

1. Weisgraber KH, Rall SC Jr, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256:9077-83.
2. Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A. 1982;79:4696-700.
3. Moysich KB, Freudenheim JL, Baker JA, Ambrosone CB, Bowman ED, Schisterman EF, et al. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog. 2000;27:2-9.
4. Niemi M, Kervinen K, Kiviniemi H, Lukkarinen O, Kyllönen AP, Apaja-Sarkkinen M, et al. Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health. 2000;54:938-9.
5. Yaylim I, Bozkurt N, Yilmaz H, Isbir T, Isik N, Arikan S. The apolipoprotein E epsilon 4 allele is not a risk factor for Turkish breast cancer patients. Cancer Genet Cytogenet. 2003;146:86-7.
6. Menzel HJ, Sarmanova J, Soucek P, Berberich R, Grünewald K, Haun M, et al. Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer. 2004;90:1989-94.
7. Chang NW, Chen DR, Wu CT, Aouizerat BE, Chen FN, Hung SJ, et al. Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan. Breast Cancer Res Treat. 2005;90:257-61.
8. Chang SJ, Hou MF, Tsai SM, Kao JT, Wu SH, Hou LA, et al. Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese. Breast Cancer Res Treat. 2006;98:109-13.
9. Surekha D, Vishnupriya S, Sailaja K, Nageswara Rao D, Raghunadharao D. Influence of apolipoprotein e gene polymorphism on the risk for breast cancer. Int J Hum Genet. 2008;8:277-82.
10. Porrata-Doria T, Matta JL, Acevedo SF. Apolipoprotein E allelic frequency altered in women with early-onset breast cancer. Breast Cancer (Auckl). 2010;4:43-8.
11. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
14. Niu W, Qi Y, Qian Y, Gao P, Zhu D. The relationship between apolipoprotein E epsilon2/epsilon3/ epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res. 2009;32:1060-6.
15. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298:1300-11.
16. Carroll KK, Braden LM, Bell JA, Kalamegham R. Fat and cancer. Cancer. 1986;58(8 Suppl):1818-25.
17. Agurs-Collins T, Kim KS, Dunston GM, Adams-Campbell LL. Plasma lipid alterations in African-American women with breast cancer. J Cancer Res Clin Oncol. 1998;124:186-90.
18. Takatani O, Okumoto T, Kosano H. Genesis of breast cancer in Japanese: a possible relationship between sex hormone binding globulin (SHBG) and serum lipid components. Breast Cancer Res Treat. 1991;18 Suppl 1:S27-9.
19. Tanne JH. Apo E4 gene linked to breast cancer. BMJ. 1999;319:662.
20. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer. 2006;54:267-83.
21. Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci. 2006;97:505-9.
22. Saadat M, Ansari-Lari M. Genetic polymorphism of glutathione S-transferase T1, M1 and asthma, a meta-analysis of the literature. Pak J Biol Sci. 2007;10:4183-9.
23. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat. 2009;115:137-44.
24. Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, et al. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Breast Cancer Res Treat. 2010;124:229-35.
25. Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, et al. The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects. Breast Cancer Res Treat. 2010;123:227-31.